- Title
- Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product
- Sponsored by
- Senator Hershey
- Status
- In the Senate - Hearing 2/16 at 1:00 p.m.
- Analysis
- Fiscal and Policy Note
Synopsis
Requiring a pharmacist, or the pharmacist's designee who is under certain supervision, to inform a certain consumer of the availability of a therapeutically equivalent brand name drug that is the lowest cost alternative to the originally prescribed drug or device and the cost difference between the therapeutically equivalent drug or device and the prescribed drug; altering the cost difference of which a pharmacist is required to inform a retail consumer; requiring a certain determination to be made based on a certain drug benefit; etc.
Committees
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
Last Updated: 2/18/2021 12:48 PM